This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
6 questions investors should ask when evaluating psychedelic biotech companies. With plans to raise a $25 million fund and more than $15 million already invested, PsyMed Ventures focuses on early-stage startups developing psychedelic therapeutics. 6 questions investors should ask when evaluating psychedelic biotech companies. .
Multidomain integration is becoming a cornerstone of modern software development, bridging technologies like blockchain, biotech, and consumer applications. These cross-domain projects are no longer optional they are the future of innovation. However, combining such diverse systems presents unique challenges.
Dragonfly plans to focus its investments across all stages of blockchain and crypto-native companies, protocols, and tokens. “We It’s like investing in crypto without understanding technology is like investing in biotech without understanding biology. You’d be missing the core mechanics of what you’re investing in.”.
Deep tech, medtech/biotech, climate tech, and crypto and blockchain are all areas that investors say they’re either actively investing in or watching for signs of scale. Blockchain NZ Chair Bryan Ventura. Now, certain industries are emerging as potential areas where New Zealand can win in the tech space.
Not surprisingly, those two rounds came from the cybersecurity and biotech industries. Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in this young year. Raise , $63M, loyalty: Miami-based Raise, a gift cards and loyalty company, raised $63 millionled by Haun Ventures.
Monad Labs , $225M, blockchain: New York-based Monad Labs locked up the biggest Web3 funding round of the year thus far, collecting a $225 million funding round led by Paradigm. Monad is a layer-1 blockchain that is compatible with the Ethereum Virtual Machine but can process transactions using the same set of rules faster.
Halda Therapeutics , $126M, biotech: The big biotech round of the week came from New Haven, Connecticut-based Halda Therapeutics, a biotech startup developing therapies for prostate cancer and breast cancer, which raised a $126 million Series B extension from investors including Deep Track Capital and RA Capital Management.
April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. The company develops power-optimized chips targeting the data analytics and generative AI markets. Let’s take a look.
Nevertheless, the week saw a $1 billion round go to yet another AI startup, and biotech and blockchain also saw some big deals. AltruBio , $225M, biotech: AltruBio was the biggest biotech raise of the week, securing a $225 million Series B led by BVF Partners. Farcaster , $150M, blockchain: Is Web3 funding back?
Investors certainly put their money everywhere, from biotech to productivity tools, but they didn’t shell out a lot. Pathalys Pharma , $105M, biotech: Raleigh, North Carolina-based Pathalys Pharma isn’t new to this list — it topped it early last year. The company specializes in late stages of developing treatments for kidney disease.
Mirador Therapeutics , $400M, biotech: More big biotech raises this week. Capstan Therapeutics , $175M, biotech: Capstan Therapeutics raised a $175 million Series B led by RA Capital Management. Clasp Therapeutics , $150M, biotech: Clasp Therapeutics is the next biotech to raise huge. billion, per Crunchbase.
The San Jose, California-based startup has developed a solid-state active cooling chip — AirJet — that allows users to leverage AI even on the edge of networks or on edge devices. CinRx Pharma , $73M, biotech: This week’s top biotech round isn’t as big as it is on most weeks, but that follows the general trend. billion upfront.
Applied Intuition , $250M, autonomous vehicles: Autonomous vehicle software developer Applied Intuition locked up a $250 million Series E valuing the company at $6 billion — a 67% uptick in value from its previous round. Like many biotech startups raising big money currently, Zephyr is bringing AI to the sector.
Web3 Berachain , an Ethereum-compatible blockchain for financial applications, raised $69 million by selling digital tokens led by BH Digital and Framework Ventures. The bear-themed blockchain company based in the Cayman Islands was valued at $1.5 Let’s look at March’s new unicorn startups by sector. billion in the deal.
The company is developing advanced small modular nuclear reactors for clean energy generation. Terray Therapeutics , $120M, biotech: Los Angeles-based Terray Therapeutics, a biotech startup developing small molecule drug therapeutics, raised a $120 million Series B led by new investor Bedford Ridge Capital and existing investor NVentures.
However, the city’s tech scene is apparently lackluster when it comes to legal tech, blockchain and consumer-facing technology. Weak in blockchain and consumer. Weak in deep tech discovery, especially in biotech/therapeutics. This offer is only available to readers in the UK Europe and expires on June 30, 2021.
The Great Expectations of Crypto and Blockchain , with MoneyGram. Building the Visual Economy Through Developer-Led Innovation , with Cloudinary. Web3, Crypto, Blockchain — Unlocking Prosperity for Tech and Creative Industries in Africa , with Fast Forward Venture Studio. BF 200 Fast-Pitch Sessions — Heath Tech and Biotech. .
The city appears to be strong in areas such as travel, AI, cybersecurity, fintech, agritech, travel tech, biotech, sports tech, and VR. The blockchain/crytpo scene could do with some improvement, according to a few respondents. Blockchain could be improved. We have some of the top incubators and accelerator programs in Spain.
The investment scene is described variously as focusing on software, clean tech, life sciences, biotech, organoids, 3D bioprinting, AI and VR/AR. A lot of focus is on life sciences, biotech, as there is a lot of research at the Utrecht science park and also spin-offs. We could do with a bit stronger IT education (developers!).
The company continued hiring developers and marketers and raised the team by around 10%. Developed a SaaS-based white-label web3 platform that opens revenue streams and strengthens community engagement. Ahrefs claims to have become a $100 million company in annual revenue without venture capital. Incorporated in Delaware, USA.
The startup has developed a business management platform for the laundry business — including laundromats, dry cleaners and even shared laundry rooms — which seems like a very specific niche but one that doesn’t go out of style. Basically, the blockchain aims to ensure owners are compensated when their IP is used.
Data61, Treasury to review the future of blockchain technology in Australia - ZDNet. Startup Spotlight: Reflect helps developers add data visualizations to their apps. Designer proteins open up biotech frontiers. The following are some of the hot topics we are tracking in the technology ecosystem: Technology Ticker.
Other investors felt that a broader range of industries, like fintech and biotech, would eventually produce the biggest companies in the country. JoyTunes, led by Yuval Kaminka has developed a music-learning platform that has skyrocketed in 2020. We are more cautious about particular industries. For us, we are seeking larger exits.
Research and development equipment. Agri-tech entrepreneurs have developed an innovative IoT based software, that can track weather conditions and provide accurate information about the quality and type of soil. Blockchain for cross-border trading. Agricultural biotechnology also helps in the development of innovative foods.
The San Jose, California-based firm, which is developing its AI inference chip for both the generative AI and automotive industries, raised a $102 million Series C co-led by Celesta Capital and GreatPoint Ventures. Last year such startups saw only $1.2 billion in 66 deals — per Crunchbase data — after raking in more than $2 billion in 2022.
Advanced Technology Development Center/ATDC (Georgia Tech). Being one of the most renowned tech incubators, Advanced Technology Development Center (ATDC) has been listed among the world-changing accelerators by Forbes, side by side with Y ?ombinator The annual event tracks activity in the development of the Data Center Industry.
At this conference, gain insight from an expert speaking faculty, navigate regulatory changes, develop strategies for data and document anonymization, achieve meaningful patient engagement and spend your time with a laser focus on data sharing. Pharma/Biotech: $3,295. Below you’ll find the list of conferences taking place in Q1 and Q2.
Bankrolling the Blockchain with a16z Crypto. Launched in 2020, Solana gained worldwide renown for being one of the fastest blockchains with a rapidly growing developer ecosystem. The Great Expectations of Crypto and Blockchain. But first, he’s tackling another problem: soggy delivery. Speeding Up Crypto.
CEO & Co-founder, Slingshot Aerospace as they discuss what lies on the other side of this economic turbulence and the role the government can play as a non-equity investor supporting development of critical technologies in the national interest. Solving the Supply Chain Crisis with Autonomous Trucks. TC Plus Stage | 2:10 pm.
Its preferred sectors are ‘techbio’ (by which he means tech-focused biotech businesses), software (especially software as a service, or SAAS), energy and fintech. This should be second nature to scientists, who make progress by disproving one hypothesis in order to develop a better one.
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content